Chamorro C, Lobatón E, Bonache M C, De Clercq E, Balzarini J, Velázquez S, San-Félix A, Camarasa M J
Instituto de Química Médica (C.S.I.C.), Juan de la Cierva 3, 28006-Madrid, Spain.
Bioorg Med Chem Lett. 2001 Dec 3;11(23):3085-8. doi: 10.1016/s0960-894x(01)00635-7.
N-3-Benzyloxycarbonylmethyl- and N-3-carboxymethyl-TBDMS-substituted nucleosides were synthesized and evaluated for activity against HIV replication. It was found that the N-3-carboxymethyl-TBDMS-substituted nucleosides were specific inhibitors of HIV-1 replication. They should be considered as members of a novel and original class of NNRTIs.
合成了N-3-苄氧羰基甲基和N-3-羧甲基-TBDMS取代的核苷,并评估了它们对HIV复制的活性。发现N-3-羧甲基-TBDMS取代的核苷是HIV-1复制的特异性抑制剂。它们应被视为一类新型且独特的非核苷类逆转录酶抑制剂(NNRTIs)的成员。